- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT03034070
Whole-Body 3D T1-weighted MR Imaging Anatomical Sequences: GE mDixon vs FSE (View) Approaches in Prostate Cancer. (TFE-TVE)
Whole-Body 3D T1-weighted MR Imaging Anatomical Sequences: GE mDixon vs FSE (View) Approaches in Prostate Cancer. Comparison of Diagnostic Performance of GE mDixon and FSE, for Bone and Node Staging in Patients With Prostate Cancer.
Study Overview
Status
Conditions
Intervention / Treatment
Detailed Description
Whole-body (WB) magnetic resonance (MR) imaging has increasingly been used for the screening of bone and soft-tissue metastases in patients with prostate cancer (1). A limitation for its implementation is the 45-60 minutes duration of current WB MRI examinations. Conventional WB MR imaging studies consisted of anatomical two-dimensional (2D) T1-weighted and fat-suppressed fluid-sensitive (proton-density fat-saturated (PDFS) or short-tau inversion-recovery (STIR)) and of a functional diffusion-weighted imaging sequence. Recent research has confirmed the feasibility of replacing the 2D anatomical sequences by a single three-dimensional (3D) T1-weighted fast spin echo (FSE) sequence (2).
This study will assess and compare the diagnostic performances and image quality of two WB 3D T1-weighted MR imaging sequences for bone and node staging in patients with prostate cancer : the FSE sequence and a gradient echo (GE) sequence. The latter sequence's main feature is its acquisition time of approximately 1.5 minutes, compared to 18 min for the FSE sequence, reducing the exam's acquisition time, patient discomfort and increasing machine availability.
The aim of this study is to evaluate the feasibility of the replacement of the WB 3D T1-weighted FSE MR imaging sequence by the WB 3D T1-weighted GE MR imaging sequence.
Study Type
Enrollment (Actual)
Phase
- Not Applicable
Contacts and Locations
Study Locations
-
-
-
Brussels, Belgium, 1200
- Cliniques Universitaires Saint-Luc
-
-
Participation Criteria
Eligibility Criteria
Ages Eligible for Study
Accepts Healthy Volunteers
Genders Eligible for Study
Description
Inclusion Criteria:
- prostate cancer with high risk for metastases
Exclusion Criteria:
- contraindications to MRI
Study Plan
How is the study designed?
Design Details
- Primary Purpose: DIAGNOSTIC
- Allocation: NA
- Interventional Model: SINGLE_GROUP
- Masking: NONE
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
---|---|
OTHER: Diagnostic performance 3D T1
A 3D T1-weighted GE mDixon MR imaging sequence will be added to the routine 3D T1-weighted FSE sequence.
mDixon sub-sequences (Fat and In Phase) are compared to 3D T1-weighted FSE in terms of diagnostic accuracy for M and N staging in prostate cancer patients: Fat, In Phase, Fat+In Phase and the routine 3D T1 will be analyzed separately, blindly and randomly.
|
Although non-invasive, the prospective addition of a new MRI sequence to a routine MRI protocol is considered by our ethical committee as an "interventional" study.
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
Diagnostic performances of 3D GE T1 sub-sequences
Time Frame: 3 months
|
Sensitivity, sensibility, positive and negative Predictive Values (PV) will be calculated with the results of each reading, and compared. The physical parameters of the different techniques will also be compared (Signal-to-noise ratio, contrast-to-noise ratio, ...). |
3 months
|
Collaborators and Investigators
Publications and helpful links
General Publications
- Lecouvet FE, El Mouedden J, Collette L, Coche E, Danse E, Jamar F, Machiels JP, Vande Berg B, Omoumi P, Tombal B. Can whole-body magnetic resonance imaging with diffusion-weighted imaging replace Tc 99m bone scanning and computed tomography for single-step detection of metastases in patients with high-risk prostate cancer? Eur Urol. 2012 Jul;62(1):68-75. doi: 10.1016/j.eururo.2012.02.020. Epub 2012 Feb 17.
- Pasoglou V, Michoux N, Peeters F, Larbi A, Tombal B, Selleslagh T, Omoumi P, Vande Berg BC, Lecouvet FE. Whole-body 3D T1-weighted MR imaging in patients with prostate cancer: feasibility and evaluation in screening for metastatic disease. Radiology. 2015 Apr;275(1):155-66. doi: 10.1148/radiol.14141242. Epub 2014 Dec 15.
Study record dates
Study Major Dates
Study Start
Primary Completion (ACTUAL)
Study Completion (ACTUAL)
Study Registration Dates
First Submitted
First Submitted That Met QC Criteria
First Posted (ESTIMATE)
Study Record Updates
Last Update Posted (ACTUAL)
Last Update Submitted That Met QC Criteria
Last Verified
More Information
Terms related to this study
Additional Relevant MeSH Terms
Other Study ID Numbers
- TFE TVE
Plan for Individual participant data (IPD)
Plan to Share Individual Participant Data (IPD)?
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Metastasis
-
MedtronicNeuroCompletedMetastasis Spine | Metastasis to BoneUnited States, Luxembourg, Germany, France, Canada
-
The Netherlands Cancer InstituteCompletedLymph Node Metastasis | Image-guide SurgeryNetherlands
-
M.D. Anderson Cancer CenterCompletedHead and Neck CancerUnited States
-
University Hospital, LinkoepingSahlgrenska University Hospital, Sweden; Medical Research Council of Southeast...RecruitingColorectal Cancer Metastatic | Chemotherapy Effect | Tumour Metastasis | Tumor GrowthSweden
-
Universitätsklinikum Hamburg-EppendorfRecruitingColon Carcinoma | Lymph Node MetastasesGermany
-
Li MinRecruiting
-
Da FuGanzhou City People's HospitalRecruiting
-
University of Mississippi Medical CenterCompletedMetastasisUnited States
-
Sun Yat-sen UniversityNot yet recruitingBreast Cancer | Ipsilateral Supraclavicular Lymph Node Metastasis
-
Loyola UniversityUnknownSpinal MetastasisUnited States
Clinical Trials on Diagnostic performance 3D T1
-
Fondation Ophtalmologique Adolphe de RothschildCompleted
-
University of MalayaCompletedPostoperative Delirium | Diagnosis, Psychiatric
-
Fondation Ophtalmologique Adolphe de RothschildNot yet recruiting
-
Centre Hospitalier St AnneAssistance Publique - Hôpitaux de Paris; National Research Agency, France; CENIR... and other collaboratorsUnknown
-
University Hospital, Strasbourg, FranceNot yet recruitingMild Head Trauma With Risk of Complications
-
Centre Hospitalier Universitaire, AmiensCompletedTransbronchial Biopsies | Peripheral Lung LesionFrance
-
ICE Intelligent Healthcare Co., LtdNot yet recruitingAtrial Fibrillation | Arrhythmias, Cardiac | Atrial Septal Defect | Patent Foramen Ovale | Valve Disease, Heart | Supraventricular Tachycardia | Structural Heart DiseasesChina
-
Capital Medical UniversityRecruitingImage | Abnormal Cerebral Venous Sinus Morphology | Internal Jugular Vein StenosisChina
-
Arturo Jauretche National UniversityUniversity of Buenos Aires; Hospital El Cruce; Universidad Nacional de La Plata; National University of CuyoRecruiting
-
Hospices Civils de LyonUnknown